This may include “cytokine-cytokine receptor interaction,” “IL-17 signaling pathway,” “JAK-STAT signaling pathway,” “TNF signaling pathway,” “chemokine signaling pathway,” “transcriptional misregulation in cancer,” “MAPK signaling pathway,” and “PI3K-Akt signaling pathway.” This evidence concerns the gene IL17A and cancer.